Best Practices for Developing and Protecting Strong Brands
This InfoPak aims to assist in-house and outside counsel alike in counseling their clients toward selecting, achieving, and protecting strong brands.
This InfoPak aims to assist in-house and outside counsel alike in counseling their clients toward selecting, achieving, and protecting strong brands.
This InfoPAK explores the case law and best principles for handling workplace investigations into employee claims of harassment and other alleged improper treatment in light of the defense provided in Faragher v. City of Boca Raton and the shield that is the attorney-client and attorney work product privileges. This InfoPAK is meant to provide an overview of the Faragher defense (especially in light of recent developments in case law) as well as the salient privileges, and then provide employers with insight on the best practices for protecting the Faragher defense as well as, where possible, the privileges, while proactively addressing employee concerns.
The Stark Law has promulgated complicated regulations for transactions involving payments to physicians. All facets of the healthcare industry also face on a daily basis the shadow of government prosecutors focused on violations of the federal anti-kickback statute. These laws involve both criminal prosecution and civil liability, and in-house attorneys have at times been prosecuted as individual defendants. Enforcement is expanding to cover individual physicians as prescribers of company products and providers of services to companies, such as consulting and clinical investigator services, and to physician ownership of medical device distributors. Looming over healthcare companies and individuals is the potential to be debarred from participation in Medicare, Medicaid & other federal health care programs. In addition, in-house counsel need to be aware of obscure state laws on the issues of physician self-referral prohibition and anti-kickbacks. This program will discuss the government’s new enforcement trend and mechanisms that in-house counsel can employ to reduce these risks.
This Standard Document and the integrated drafting notes are for guidance in the preparation of a patent and know-how license agreement from the perspective of the licensor.
This Quick Overview addresses how the Precision Medicine Initiative (the "PMI") allows targeted therapies to be deployed that are more likely to be efficacious, less likely to lead to adverse side effects, and, in many circumstances, more cost-effective for both the patient and society at large than current approaches to many different illnesses.
If you’ve been a litigator on the outside, welcome to a whole new ball game. As in-house counsel, your focus is not just on getting those pleadings filed, but also implementing litigation holds, managing outside counsel, conducting investigations, analyzing your position, determining strategy, and much more. And it is not just about conducting the litigation. It is also about taking steps and creating programs to avoid litigation, performing cost benefit analysis and risk assessment to determine whether to get in, stay in, or get out, and conducting a thorough post mortem of each case so that you acquire a very long educational list of “lessons learned” that will direct you in the future. Come learn from our panel of experts who have “been there, done that.”
Learn the benefits of a strategic HR approach that looks at talent management, how high lawyers can go and what skill sets you’ll need to climb the ladder. Participate in the discussion about a hypothetical Law Department and how to structure it so that both the company and the individual lawyers can benefit.
This InfoPAK (now known as ACC Guides) provides an overview of key issues to address, the content of each of these document, intellectual property issues, and employment issues on an international joint venture. In addition, this document provides an analysis of the various legal structures that are commonly used as vehicles for international joint ventures control and minority protection at board and shareholder level, key competition issues, and deadlock and termination provisions in the context of an international corporate joint venture.
The purpose of this InfoPAK is to assist corporate counsel in understanding and making decisions about conflicts and waivers. Included is an overview of the rules relating to the three principal kinds of conflict of interest that result in conflicts waiver requests, as well as a discussion of the issues corporate counsel should consider when reviewing a request for a conflicts waiver.